These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 16824708

  • 1. Biodegradable scleral implants as new triamcinolone acetonide delivery systems.
    Felt-Baeyens O, Eperon S, Mora P, Limal D, Sagodira S, Breton P, Simonazzi B, Bossy-Nobs L, Guex-Crosier Y, Gurny R.
    Int J Pharm; 2006 Sep 28; 322(1-2):6-12. PubMed ID: 16824708
    [Abstract] [Full Text] [Related]

  • 2. Development of biodegradable controlled release scleral systems of triamcinolone acetonide.
    Blatsios G, Tzimas AS, Mattheolabakis G, Panagi Z, Avgoustakis K, Gartaganis SP.
    Curr Eye Res; 2010 Oct 28; 35(10):916-24. PubMed ID: 20858113
    [Abstract] [Full Text] [Related]

  • 3. A biodegradable drug delivery system for the treatment of postoperative inflammation.
    Eperon S, Bossy-Nobs L, Petropoulos IK, Gurny R, Guex-Crosier Y.
    Int J Pharm; 2008 Mar 20; 352(1-2):240-7. PubMed ID: 18093765
    [Abstract] [Full Text] [Related]

  • 4. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
    Robinson MR, Lee SS, Kim H, Kim S, Lutz RJ, Galban C, Bungay PM, Yuan P, Wang NS, Kim J, Csaky KG.
    Exp Eye Res; 2006 Mar 20; 82(3):479-87. PubMed ID: 16168412
    [Abstract] [Full Text] [Related]

  • 5. Improved anti-inflammatory effects in rabbit eye model using biodegradable poly beta-amino ester nanoparticles of triamcinolone acetonide.
    Sabzevari A, Adibkia K, Hashemi H, De Geest BG, Mohsenzadeh N, Atyabi F, Ghahremani MH, Khoshayand MR, Dinarvand R.
    Invest Ophthalmol Vis Sci; 2013 Aug 15; 54(8):5520-6. PubMed ID: 23833065
    [Abstract] [Full Text] [Related]

  • 6. A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide.
    Kim YM, Lim JO, Kim HK, Kim SY, Shin JP.
    Eur J Pharm Biopharm; 2008 Sep 15; 70(1):179-86. PubMed ID: 18667297
    [Abstract] [Full Text] [Related]

  • 7. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M, Li X, Liu J, Han Y, Cheng L.
    J Control Release; 2015 Apr 10; 203():109-17. PubMed ID: 25700623
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes.
    Lee SJ, Kim ES, Geroski DH, McCarey BE, Edelhauser HF.
    Invest Ophthalmol Vis Sci; 2008 Oct 10; 49(10):4506-14. PubMed ID: 18503001
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transcleral delivery of triamcinolone acetonide and ranibizumab to retinal tissues using macroesis.
    Singh RP, Mathews ME, Kaufman M, Riga A.
    Br J Ophthalmol; 2010 Feb 10; 94(2):170-3. PubMed ID: 20139290
    [Abstract] [Full Text] [Related]

  • 11. Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone--an in vivo study.
    Peng YJ, Kau YC, Wen CW, Liu KS, Liu SJ.
    J Biomed Mater Res A; 2010 Aug 10; 94(2):426-32. PubMed ID: 20186737
    [Abstract] [Full Text] [Related]

  • 12. Sustained release of triamcinolone acetonide from an episcleral plaque of multilayered poly-ε-caprolactone matrix.
    Meng Y, Sun S, Li J, Nan K, Lan B, Jin Y, Chen H, Cheng L.
    Acta Biomater; 2014 Jan 10; 10(1):126-33. PubMed ID: 24076072
    [Abstract] [Full Text] [Related]

  • 13. Biocompatible poly(methylidene malonate)-made materials for pharmaceutical and biomedical applications.
    Breton P, Larras V, Roy D, Sagodira S, Limal D, Bonnafous D, Colin N, Bru N, Fattal E, Couvreur P.
    Eur J Pharm Biopharm; 2008 Mar 10; 68(3):479-95. PubMed ID: 17897815
    [Abstract] [Full Text] [Related]

  • 14. Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.
    Kamppeter BA, Cej A, Jonas JB.
    Ophthalmology; 2008 Aug 10; 115(8):1372-5. PubMed ID: 18355920
    [Abstract] [Full Text] [Related]

  • 15. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
    Li J, Lan B, Li X, Sun S, Lu P, Cheng L.
    J Control Release; 2016 Dec 10; 243():78-85. PubMed ID: 27717742
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of different preparation methods for a preservative free triamcinolone acetonide preparation for intravitreal administration: a validated stability indicating HPLC-method.
    Korodi T, Lachmann B, Kopelent-Frank H.
    Pharmazie; 2010 Dec 10; 65(12):860-6. PubMed ID: 21284253
    [Abstract] [Full Text] [Related]

  • 17. Sustained delivery of growth factors from methylidene malonate 2.1.2-based polymers.
    Désiré L, Mysiakine E, Bonnafous D, Couvreur P, Sagodira S, Breton P, Fattal E.
    Biomaterials; 2006 Apr 10; 27(12):2609-20. PubMed ID: 16364430
    [Abstract] [Full Text] [Related]

  • 18. Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes.
    Yi NY, Davis JL, Salmon JH, Gilger BC.
    Vet Ophthalmol; 2008 Sep 10; 11 Suppl 1():15-9. PubMed ID: 19046265
    [Abstract] [Full Text] [Related]

  • 19. Release profile and transscleral permeation of triamcinolone acetonide loaded nanostructured lipid carriers (TA-NLC): in vitro and ex vivo studies.
    Araújo J, Garcia ML, Mallandrich M, Souto EB, Calpena AC.
    Nanomedicine; 2012 Aug 10; 8(6):1034-41. PubMed ID: 22115598
    [Abstract] [Full Text] [Related]

  • 20. Ocular tissue distribution of betamethasone after anterior-episcleral, posterior-episcleral, and anterior-intrascleral placement of nonbiodegradable implants.
    Okabe K, Kimura H, Okabe J, Ogura Y.
    Retina; 2007 Aug 10; 27(6):770-7. PubMed ID: 17621189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.